Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: Results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)

Peter L. Greenberg, Zhuoxin Sun, Kenneth B. Miller, John M. Bennett, Martin S. Tallman, Gordon Dewald, Elisabeth Paietta, Richard Van Der Jagt, Jessie Houston, Mary L. Thomas, David Cella, Jacob M. Rowe

Research output: Contribution to journalArticlepeer-review

160 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: Results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds